← Healthspan Infrastructure research Healthspan · H6 · Intervene

Intervene stocks

By Scott McLeodPublished by PXS Research Updated October 23, 2026

Therapies and devices that create demand for the healthspan toll-road stack.

37 mapped stocks0 company-level buy signals10 technologies

H6 capability map

Intervene technologies

Open a technology to understand the capability, evidence framework and every directly mapped public stock.

Adipose tissue processing & autologous fat transfer systems

0 stocks mapped · Open research GuideCurated

Gene and Cell Therapy Platforms

0 stocks mapped · Open research Deep Dive

GLP-1 and Metabolic Therapeutics

4 stocks mapped · Open research Deep Dive

Healthspan Therapeutics

34 stocks mapped · Open research Deep Dive

Immunology Inflammation and Rare Disease

3 stocks mapped · Open research GuideCurated

Medical Imaging Systems

0 stocks mapped · Open research Guide

Oncology and CNS Therapeutics

7 stocks mapped · Open research Deep Dive

Orthopedic Implants & Digital Surgery

2 stocks mapped · Open research Deep Dive

Structural Heart & Transcatheter Valves

4 stocks mapped · Open research Deep Dive

Surgical Robotics

4 stocks mapped · Open research

Intervene stock picks

SONYSony Group CorpMedical Imaging Systems Intervene WATCH●●○○○ ●●○○○ $89.70Research target 10/23/26Last reviewed BFLYButterfly Network, Inc.Medical Imaging Systems Intervene WATCH●●○○○ ●●○○○ $11.73Research target 10/22/26Last reviewed CYHCOMMUNITY HEALTH SYSTEMS INCMedical Imaging Systems Intervene WATCH●●○○○ ●●○○○ $2.96Research target 10/22/26Last reviewed HCAHCA Healthcare, Inc.Medical Imaging Systems Intervene WATCH●●○○○ ●●○○○ $471.75Research target 10/22/26Last reviewed HYPRHyperfine, Inc.Medical Imaging Systems Intervene WATCH●●○○○ ●●○○○ $1.80Research target 10/22/26Last reviewed NNOXNano-X Imaging Ltd.Medical Imaging Systems Intervene WATCH●●○○○ ●●○○○ $4.19Research target 10/22/26Last reviewed RDNTRadNet, Inc.Medical Imaging Systems Intervene WATCH●●○○○ ●●○○○ $84.14Research target 10/22/26Last reviewed THCTENET HEALTHCARE CORPMedical Imaging Systems Intervene WATCH●●○○○ ●●○○○ $279.55Research target 10/22/26Last reviewed UHSUNIVERSAL HEALTH SERVICES INCMedical Imaging Systems Intervene WATCH●●○○○ ●●○○○ $185.42Research target 10/22/26Last reviewed VREXVarex Imaging CorpMedical Imaging Systems Intervene WATCH●●○○○ ●●○○○ $19.00Research target 10/22/26Last reviewed GMEDGlobus Medical IncExcelsiusGPS robotic spine surgery + Excelsius3D imaging Intervene POOL●●○○○ ●●○○○ $91.21Research target 10/12/26Last reviewed IARTIntegra LifeSciences HoldingsNeurosurgery & reconstructive surgical devices (dural repair, collagen matrix) Intervene POOL●●●○○ ●●●○○ $15.76Research target 10/12/26Last reviewed ACADAcadia Pharmaceuticals Inc.NUPLAZID (pimavanserin) for Parkinson's disease psychosis; DAYBUE (trofinetide) for Rett syndrome Intervene WATCH●○○○○ ●○○○○ $31.23Research target 9/30/26Last reviewed ARWRArrowhead Pharmaceuticals, Inc.RNAi therapeutics (plozasiran FCS/CVD, zodasiran lipid disorders); TRiM delivery platform Intervene WATCH●○○○○ ●○○○○ $97.72Research target 9/30/26Last reviewed BCRXBioCryst Pharmaceuticals, Inc.Oral small-molecule rare disease (Orladeyo/orberalin for HAE); infectious disease (RAPIVAB) Intervene WATCH●○○○○ ●○○○○ $18.04Research target 9/30/26Last reviewed GILDGilead Sciences, Inc.HIV (Biktarvy, Descovy, lenacapavir); oncology CAR-T (Yescarta, Tecartus); liver disease Intervene WATCH●○○○○ ●○○○○ $153.94Research target 9/30/26Last reviewed GSKGSK plcVaccines (Shingrix, Arexvy); specialty medicines (HIV, respiratory); immunology Intervene WATCH●○○○○ ●○○○○ $614.27Research target 9/30/26Last reviewed IONSIonis Pharmaceuticals, Inc.Antisense RNA therapeutics (TRYNGOLZA, SPINRAZA, WAINUA); neurology, cardiovascular Intervene WATCH●○○○○ ●○○○○ $82.98Research target 9/30/26Last reviewed TGTXTG Therapeutics, Inc.Anti-CD20 B-cell therapies (BRIUMVI/ublituximab for MS); B-cell malignancy pipeline Intervene WATCH●○○○○ ●○○○○ $65.76Research target 9/30/26Last reviewed MDTMedtronicStructural heart, cardiac surgery Intervene WATCH●●●○○ ●●●○○ $100.94Research target 9/13/26Last reviewed REGNRegeneronDurable therapeutic platforms Intervene WATCH●●○○○ ●●○○○ $865.86Research target 9/6/26Last reviewed EWEdwards LifesciencesStructural heart, TAVR Intervene WATCH●●●○○ ●●●○○ $105.70Research target 9/5/26Last reviewed ALNYAlnylam PharmaceuticalsRNAi/siRNA therapeutics, GalNAc liver delivery Intervene WATCH●●○○○ ●●○○○ $334.71Research target 8/31/26Last reviewed BNTXBioNTechmRNA oncology, personalized cancer vaccines Intervene WATCH●●○○○ ●●○○○ $121.43Research target 8/31/26Last reviewed MRNAModernamRNA therapeutics, personalized cancer vaccines Intervene WATCH●●○○○ ●●○○○ $100.63Research target 8/31/26Last reviewed MRKMerckOncology, vaccines, immunology Intervene WATCH●●○○○ ●●○○○ $160.55Research target 8/30/26Last reviewed ZBHZimmer BiometOrthopedics, implants Intervene WATCH●●●○○ ●●●○○ $106.09Research target 8/30/26Last reviewed GEHCGE HealthCareImaging systems Intervene WATCH●●○○○ ●●○○○ $78.01Research target 8/16/26Last reviewed VKTXViking TherapeuticsVK2735 dual agonist Intervene WATCH●●○○○ ●●○○○ $94.93Research target 8/16/26Last reviewed ABBVAbbVieImmunology, oncology, neuroscience Intervene WATCH●●○○○ ●●○○○ $297.80Research target 7/31/26Last reviewed AMGNAmgenMariTide monthly injectable Intervene WATCH●●●●● ●●●●● $422.22Research target 7/31/26Last reviewed BSXBoston ScientificInterventional devices Intervene WATCH●●●○○ ●●●○○ $55.03Research target 7/31/26Last reviewed LLYEli LillyTirzepatide, Foundayo, retatrutide Intervene WATCH●●○○○ ●●○○○ $1399.98Research target 7/31/26Last reviewed NVONovo NordiskSemaglutide, CagriSema Intervene WATCH●●○○○ ●●○○○ $40.00Research target 7/31/26Last reviewed NVSNovartisGene therapy, radioligand Intervene WATCH●●○○○ ●●○○○ $136.00Research target 7/31/26Last reviewed SYKStrykerOrthopedics, Mako robotics Intervene WATCH●●●○○ ●●●○○ $350.82Research target 7/31/26Last reviewed VRTXVertex PharmaceuticalsCystic fibrosis, cell therapy, Casgevy Intervene WATCH●●○○○ ●●○○○ $591.60Research target 7/31/26Last reviewed

Funds investing in